Acro Biomedical Co., Ltd. Announces Earnings Results for the Year Ended September 30, 2018
December 28, 2018 at 09:01 pm
Share
Acro Biomedical Co., Ltd. announced earnings results for the year ended September 30, 2018. For the year, the company reported revenue of $8,014,500 against $510,000 a year ago. Income before provision for income taxes was $511,887 against loss of $2,248 a year ago. Net income was $419,660 or against loss of $2,248 a year ago. Basic and dilutive income per share of common stock was $0.01 against loss of $0.00 a year ago.
Acro Biomedical Co., Ltd. is principally engaged in the business is the sale of cordyceps related products. The Company is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The Company's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus, which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The Company is involved in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. It sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
ACRO BIOMEDICAL CO., LTD. 
